KAREN LOCKHEART: Open Payments
NPI 1831638824 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 17 payments from 8 companies in 2025. Trend: 2023 $643 · 2024 $619 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $160 |
| Novo Nordisk Inc | 1 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $42 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Corcept Therapeutics | 1 | $25 |
| Exact Sciences Corporation | 1 | $17 |
Products named: MOUNJARO, Ozempic, Kerendia, AIRSUPRA, JARDIANCE, TRELEGY ELLIPTA, Korlym, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
